2022 Land Rover Defender SE
3.0 L • I6 • 395 hp • 4×4 • AT
SALEP7RU6N2095393
Sales history: 1
Highlights
Condition
Not provided
Seller
Insurance • AIG Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
3.0 L • I6 • 395 hp • 4×4 • AT
Odometer
43,015 mi ≈ 69,226 km
Primary damage
Rear end
Docs
Salvage
Extra
Auction
VIN
SALEP7RU6N2095393
Lot number
87873935
Copart
Sale status
Sold
Seller type
Insurance
Seller
AIG Insurance
Location
Dallas South, TX
Description
Fuel type
Gasoline
Body color
Green
Body type
SUV
Generation
L663
Trim
SE
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Land Rover models
2022 Land Rover Defender SE • 3.0 L • I6 • 395 hp • 4×4 • Automatic • Copart Lot: 87873935 • VIN: SALEP7RU6N2095393
Find out more about this 2022 Land Rover Defender SE, available at the Copart salvage car auction as lot 87873935 in Dallas South, TX. This car has Rear end main damage. It is listed with start condition code. Odometer shows 43,015 mi. This Green Land Rover Defender SUV is equipped with Gasoline 3.0 L engine, 4×4 drivetrain, Automatic transmission. Check the vehicle history report for SALEP7RU6N2095393 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
